In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MabVax appoints Tom Varvaro to board

This article was originally published in Scrip

Executive Summary

MabVax Therapeutics, a clinical-stage cancer immunotherapy company, has named Tom Varvaro to its board of directors as an independent director. The appointment of Mr Varvaro brings the total number of directors to seven. Mr Varvaro, age 45, has served as the CFO of ChromaDex since January 2004 and served as a director from March 2006 until May 2010.  At ChromaDex, he is responsible for overseeing all aspects of the company's accounting, IT, intellectual property, and human resources. 

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC028388

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel